Dexamethasone as adjuvant therapy in the treatment of invasive meningococcal diseases.
OBJECTIVE
With this study we want to evaluate the role of dexamethasone adjuvant treatment in different clinical forms of invasive meningococcal diseases. WORK METHODS: This was a randomized, open label trial that was conducted in 147 individuals with meningococcal sepsis. All of the cases have been divided in two groups: (1) Cases with meningococcal disease and CNS infection, and (2) Cases with meningococcal disease and no affection of the CNS. Cases from both groups were treated with dexamethasone, 0.15 mg/kg, every 6 h, for 4 (four) days, as adjuvant therapy. Cases which were not treated with dexamethasone were used as control group.


METHODS
From overall number of cases, in 130 of them, the meningococcal disease was accompanied with meningitis; in other 17 cases only signs of sepsis were present. In both clinical forms, the dexamethasone was used in 92 cases. The higher mortality rate is registered among the cases without meningitis, 17.65%, compared with 6.92% which is registered among cases with meningitis. The overall mortality rate among all cases was 8.2%. The significant difference was recorded only on CSF sugar level between two groups (treated or not with dexamethasone) on the day 1-4 of the hospitalization.


CONCLUSIONS
Our epidemiological data are in correlation with data from other epidemiological studies. Most of the cases 69.4%, were more than 12 hours sick at home before the hospitalization, 7.5 % of cases were hospitalized within 12 hours from the onset of the diseases, while 23.1% of cases data are missing. This is in correlation with similar data from other studies.


CONCLUSIONS
Dexamethasone has a limited effect on outcome of the invasive meningococcal disease. Dexamethasone had some effect only during the days of administration in cases with clinical form of sepsis with meningitis, by normalizing the values of CSF sugar earlier.
Department of Infectious Diseases, University Clinical Center of Kosovo, Prishtina, Kosova. drtolaj@yahoo.com
Ilir
I
Tolaj
Shemsedin
S
Dreshaj
Emine
E
Qehaja
Jasmina
J
Tolaj
Teuta
T
Doda-Ejupi
Murat
M
Mehmeti
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008589:Meningococcal Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D055815:Young Adult
D005938:Glucocorticoids; D003907:Dexamethasone